Biolife Solutions (BLFS) Liabilities from Discontinued Operations (2023 - 2024)
Biolife Solutions (BLFS) reported Liabilities from Discontinued Operations of 616000.0 for Q4 2024, down 90.53% year-over-year from 6503000.0 in Q1 2024, and down 90.53% on a QoQ basis from 6503000.0 in Q4 2023.
Biolife Solutions (BLFS) has 2 years of Liabilities from Discontinued Operations data on file, last reported at 616000.0 in Q4 2024.
- Quarterly Liabilities from Discontinued Operations fell 90.53% year-over-year to 616000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 616000.0 (down 90.53% YoY) and the FY2024 annual result came in at 616000.0, down 90.53% from the prior year.
- Liabilities from Discontinued Operations eased to 616000.0 in Q4 2024 per BLFS's latest filing, from 6503000.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 6503000.0 in Q4 2023 and bottomed at 616000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Biolife Solutions | 1.20 Bn | 1.12 Bn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 616,000.00 |
| Dec 31, 2024 | 616,000.00 |
| Dec 31, 2023 | 6.50 Mn |
| Dec 31, 2023 | 6.50 Mn |